Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Arimoclomol

EU orphan designation number: EU/3/06/406   
Active ingredient: Arimoclomol
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: Orphazyme ApS
c/o COBIS A/S, Ole Maaløes Vej 3, DK-2200 København N, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/10/2006 Centralised Orphan - Designation EMEA/OD/053/06 (2006)5217 of 26/10/2006
13/01/2012 Centralised Orphan - Transfer of orphan designation EMEA/OD/053/06/T/01 (2012)135 of 11/01/2012